This report presents a range of statistics and facts about American company General Electric Healthcare. Since the beginning of 2023, GE Healthcare has operated as an independent company ...
In 2023, GE Healthcare recorded R&D expenses of over 1.2 billion U.S. dollars, an increase of 400 million U.S. dollars in the preceding two years. With these investments, GE Healthcare will feel ...
Shares of GE HealthCare Technologies Inc. are ending a good week on a negative note on Friday, after its former parent, now known as GE Aerospace, took advantage of the recent rally to sell off ...
UBS analyst Graham Doyle maintained a Sell rating on GE Healthcare Technologies Inc (GEHC – Research Report) yesterday and set a price target of $74.00. Graham Doyle has given his Sell rating due to a ...
The logo of French drugmaker Sanofi is seen a ... 2024 Future of Healthcategory US FDA approves GE HealthCare's diagnostic drug for heart disease September 27, 2024 Healthcare ...
Spun out from General Electric in early 2023, GE HealthCare GEHC is a top-three global leader in medical imaging. We think the company has carved out a wide economic moat as it benefits from high ...